Suppr超能文献

MRI 影像特征:肝细胞癌、肝内胆管细胞癌及联合肿瘤的 LI-RADS 2014 版诊断

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

机构信息

Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

Department of Radiology, Hospital Sírio-Libanês, Sao Paulo, Brazil.

出版信息

Abdom Radiol (NY). 2018 Jan;43(1):169-178. doi: 10.1007/s00261-017-1261-x.

Abstract

PURPOSE

To evaluate the prevalence of major and ancillary imaging features from liver imaging reporting and data systems (LI-RADS) version 2014 and their interreader agreement when comparing hepatocellular carcinoma (HCC) to intrahepatic cholangiocarcinoma (ICC) and combined tumor (cHCC-CC).

METHODS

The Institutional Review Board approved this HIPAA-compliant retrospective study and waived the requirement for patients' informed consent. Patients with resected HCC (n = 51), ICC (n = 40), and cHCC-CC (n = 11) and available pre-operative contrast-enhanced MRI were included from 2000 to 2015. Imaging features and final LI-RADS category were evaluated by four radiologists. Imaging features were compared by Fisher's exact test and interreader agreements were assessed by κ statistics.

RESULTS

None of the features were unique to either HCC or non-HCC. Imaging features that were significantly more common among HCC compared to ICC and cHCC-CC included washout (76%-78% vs. 10%-35%, p < 0.001), capsule (55%-71% vs. 16%-49%, p < 0.05), and intralesional fat (27%-52% vs. 2%-12%, p < 0.002). Features that were more common among ICC and cHCC-CC included peripheral arterial phase hyperenhancement (40%-64% vs. 10%-14%, p < 0.001) and progressive central enhancement (65%-82% vs. 14%-25%, p < 0.001). The interreader agreement was moderate for each of these imaging features (κ = 0.41-0.55). Moderate agreement was also achieved in the assignment of LR-M (κ = 0.53), with an overall sensitivity and specificity for non-HCC malignancy of 86.3% and 78.4%, respectively.

CONCLUSION

HCC and non-HCC show significant differences in the prevalence of imaging features defined by LI-RADS, and are identified by radiologists with moderate interreader agreement. Using LI-RADS, radiologists also achieved moderate interreader agreement in the assignment of the LR-M category.

摘要

目的

评估 2014 版肝脏影像报告和数据系统(LI-RADS)的主要和辅助影像学特征的流行程度,并比较肝细胞癌(HCC)与肝内胆管细胞癌(ICC)和混合型肿瘤(cHCC-CC)之间的读者间一致性。

方法

本机构审查委员会批准了这项符合 HIPAA 标准的回顾性研究,并豁免了患者知情同意的要求。该研究纳入了 2000 年至 2015 年间接受过手术切除的 HCC(n=51)、ICC(n=40)和 cHCC-CC(n=11)患者,且均有术前增强 MRI 资料。由四位放射科医生评估影像学特征和最终的 LI-RADS 分类。采用 Fisher 确切检验比较影像学特征,采用κ 统计评估读者间的一致性。

结果

没有任何特征是 HCC 或非 HCC 所特有的。与 HCC 相比,ICC 和 cHCC-CC 更常见的影像学特征包括:洗脱(76%-78%比 10%-35%,p<0.001)、包膜(55%-71%比 16%-49%,p<0.05)和瘤内脂肪(27%-52%比 2%-12%,p<0.002)。ICC 和 cHCC-CC 更常见的特征包括:外周动脉期强化(40%-64%比 10%-14%,p<0.001)和渐进性中央强化(65%-82%比 14%-25%,p<0.001)。这些影像学特征的读者间一致性为中等(κ=0.41-0.55)。LR-M 的赋值也达到了中等一致性(κ=0.53),非 HCC 恶性肿瘤的总灵敏度和特异性分别为 86.3%和 78.4%。

结论

LI-RADS 定义的 HCC 和非 HCC 的影像学特征存在显著差异,放射科医生可以通过这些特征进行识别,并且读者间的一致性为中等。放射科医生使用 LI-RADS 对 LR-M 类别进行赋值,也获得了中等的读者间一致性。

相似文献

引用本文的文献

3
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.
Eur Radiol. 2024 Nov;34(11):7025-7040. doi: 10.1007/s00330-024-10813-5. Epub 2024 May 29.
4
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.
J Cancer Res Clin Oncol. 2024 May 23;150(5):270. doi: 10.1007/s00432-024-05781-8.
5
Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma.
Eur J Radiol Open. 2024 Feb 16;12:100554. doi: 10.1016/j.ejro.2024.100554. eCollection 2024 Jun.
7
Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach.
IEEE J Biomed Health Inform. 2023 May;27(5):2456-2464. doi: 10.1109/JBHI.2023.3248489. Epub 2023 May 4.
8
Update on the Use of Artificial Intelligence in Hepatobiliary MR Imaging.
Magn Reson Med Sci. 2023 Apr 1;22(2):147-156. doi: 10.2463/mrms.rev.2022-0102. Epub 2023 Jan 26.

本文引用的文献

1
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
Ann Surg Oncol. 2017 May;24(5):1358-1366. doi: 10.1245/s10434-016-5713-2. Epub 2016 Dec 5.
2
Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Acad Radiol. 2016 Sep;23(9):1145-53. doi: 10.1016/j.acra.2016.03.014. Epub 2016 May 9.
3
Hepatocellular carcinoma.
Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18.
7
Cancer statistics, 2016.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
9
Global cancer statistics, 2012.
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验